±«ÏÊĤÊÓƵ Reports Fourth Quarter and Full Year 2023 Results
– Q4 2023 Revenues of $244.1 million, Net Loss of $31.4 million and Adjusted EBITDA of $156.8 million – Full Year 2023 Revenues of $961.5 million, Net Loss of $91.7 million and Adjusted EBITDA of $618.0 million – Identified potential medical cost savings of approximately $5.9 billion in Q4 2023, up 2.3% from Q3 2023 […]